Journal of translational medicine

Diagnosing and Managing Chronic Fatigue Syndrome (ME/CFS)

Updated

Abstract

Current diagnostic frameworks for ME/CFS rely primarily on clinical symptomatology and lack definitive biomarkers.

  • Immune dysregulation, oxidative stress, mitochondrial dysfunction, and neuroinflammation are central to the pathology of ME/CFS.
  • Pharmacological management options include immunomodulatory treatments, antioxidant therapies, mitochondrial support, and interventions targeting neuroinflammation.
  • Non-pharmacological strategies such as cognitive behavioral therapy (CBT), graded exercise therapy (GET), activity pacing, and traditional Chinese medicine (TCM) help alleviate symptom severity.
  • CBT serves as an adjunctive therapy for symptom management, while GET is contraindicated due to its potential for harm.
  • Future research should focus on developing biomarker-based diagnostic tools and optimizing combination therapies targeting multiple pathways.

Simplified

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare that they have no competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free